The Validity and Reliability Study of the Chelsea Critical Care Physical Assesment Tool

NCT ID: NCT04811638

Last Updated: 2023-08-23

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 50 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2021-01-11
• Study Completion Date: 2021-01-14

Brief Summary

This study is aimed at providing an translation and cross-cultural adaptation of Chelsea Critical Care Physical Assesment Tool (CPAx) and tested its reliability and validity.

Detailed Description

Survival has increased in the ICU due to technological developments , but physical disability after discharge has become an important problem. İntensive Care Unit Acquired Weakness(ICU-AW) is seen in most of the patients admitted in this unit. The biggest reasons for ICU-AW are; sepsis, multiple organ failure and prolonged mechanical ventilation. The use of measurement tools to evaluate disabilities during stay and after discharge in intensive care unit, is a subject that has been researched all over the world.. These measurement tools provide; monitoring and evaluation during the ICU admission and assessment efficacy of treatment in the unit. The Chelsea Critical Care Physical Assessment Tool(CPAX) has been shown to valid, reliable and to exhibited strong clinimetric properties. CPAx is a numerical measurement tool, rated according to the 6-point Guttman Scale, from complete dependence to independence and consist of ten physical function parameters. This study is aimed at providing an translation and cross-cultural adaptation of Chelsea Critical Care Physical Assesment Tool (CPAx) and tested its reliability and validity. The protocol includes a pre-test of the Turkish version on 10 patients, a final revision, and a validation on a sample of 40 İCU patients.

Conditions

ICU Patients; ICU Acquired Weakness

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Interventions

Validation of the Chelsea Critical Care Physical Assesment Tools

The validation of the CPAX tools will focus on the validity of constructs, internal consistency reliability and test-retest reliability. PFIT used for criterion validity.

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Older than 18 years
• Critical adult patients
• Patients who were hospitalized for more than 48 hours in an ICU

Exclusion Criteria

• Unstable fracture
• Limb deformities and dysfunction
• Myasthenia gravis
• Neuromuscular dysfunction
• Patients who diagnosed COVİD-19

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 85 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Medical Park Hospital Istanbul

OTHER

Sponsor Role: collaborator

Saglik Bilimleri Universitesi

OTHER

Sponsor Role: lead

Responsible Party

Mehmet Burak Uyaroğlu

Principal Investigator

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Esra Pehlivan, Ass.Prof

Role: STUDY_DIRECTOR

Saglik Bilimleri Universitesi

Mehmet Burak Uyaroğlu, PT, MSc

Role: PRINCIPAL_INVESTIGATOR

Saglik Bilimleri Universitesi

Sümeyye Akcay, PT, MSc

Role: STUDY_CHAIR

Saglik Bilimleri Universitesi

Gamze Koyutürk, PT, MSc

Role: STUDY_CHAIR

Saglik Bilimleri Universitesi

Hakan Parlak, MD

Role: STUDY_CHAIR

Istinye University Bahcesehir Hospital

Kürsat Baydilli, PhD

Role: STUDY_CHAIR

Saglik Bilimleri Universitesi

Locations

Mehmet Burak Uyaroğlu

Istanbul, , Turkey (Türkiye)

Countries

Turkey (Türkiye)

Other Identifiers

Saglik Bilimleri University

Identifier Type: -

Identifier Source: org_study_id